Medical device firm raises $12.7 million in funding round

NAPLES — Catalyst OrthoScience, a medical device company specializing on the upper extremity orthopedics market, has raised $12.7 million in an oversubscribed Series C-1 financing round led by River Cities Capital Funds.

“This funding will be instrumental in fueling rapid growth for Catalyst through increased inventory, expanded distribution and new product development,” says Brian Hutchison, chairman and CEO of Catalyst, in a statement. “The additional funding will allow us to enhance company infrastructure and hire additional talent to support our growth and to bring our novel approach to total shoulder arthroplasty to surgeons and their patients.”